Your browser doesn't support javascript.
loading
Carcinomas of the external auditory canal: Management and results: A multicenter REFCOR propensity score matching study.
Brenet, Esteban; Atallah, Sarah; Guerlain, Joanne; Moya-Plana, Antoine; Verillaud, Benjamin; Kania, Romain; Bakhos, David; Philouze, Pierre; Righini, Christian-Adrien; Bozorg, Alexis; Mérol, Jean-Claude; Labrousse, Marc; Vergez, Sébastien; Fakhry, Nicolas; Gallet, Patrice; Cullié, Dorian; Malard, Olivier; Mauvais, Olivier; Fath, Léa; Schultz, Philippe; Dufour, Xavier; Saroul, Nicolas; Evrard, Diane; Lesnik, Maria; Even, Caroline; Costes, Valérie; Thariat, Juliette; Taillandier de Gabory, Ludovic Le; Makeieff, Marc; Dubernard, Xavier; Baujat, Bertrand.
Afiliación
  • Brenet E; Department of ENT-Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France.
  • Atallah S; Department of ENT-Head and Neck Surgery, Tenon University Hospital, APHP, Sorbonne Universite, 75020 Paris, France; Doctoral School of Public Health, CESP, University of Paris Sud, 94807 Villejuif, France.
  • Guerlain J; Department of ENT-Head and Neck Surgery, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
  • Moya-Plana A; Department of ENT-Head and Neck Surgery, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
  • Verillaud B; Department of ENT-Head and Neck Surgery, Lariboisière University Hospital, APHP, 75010 Paris, France.
  • Kania R; Department of ENT-Head and Neck Surgery, Lariboisière University Hospital, APHP, 75010 Paris, France.
  • Bakhos D; Department of ENT-Head and Neck Surgery, Bretonneau University Hospital, 37000 Tours, France.
  • Philouze P; Department of ENT-Head and Neck Surgery, La Croix Rousse University Hospital, HCL, 6900 Lyon, France.
  • Righini CA; Department of ENT-Head and Neck Surgery, Grenoble Alpes University Hospital, 38043 Grenoble, France.
  • Bozorg A; Department of ENT-Head and Neck Surgery, François Mitterrand University Hospital, 21000 Dijon, France.
  • Mérol JC; Department of ENT-Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France.
  • Labrousse M; Department of ENT-Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France.
  • Vergez S; Department of ENT-Head and Neck Surgery, University Cancer Institute, 31100 Toulouse, France.
  • Fakhry N; Department of ENT-Head and Neck Surgery, University Hospital of Marseille, APHM, 13915 Marseille, France.
  • Gallet P; Department of ENT-Head and Neck Surgery, University Hospital of Nancy, 54000 Nancy, France.
  • Cullié D; Department of ENT-Head and Neck Surgery, Lacassagne Cancer Institute, 06100 Nice, France.
  • Malard O; Department of ENT-Head and Neck Surgery, University Hospital of Nantes, 44093 Nantes, France.
  • Mauvais O; Department of ENT-Head and Neck Surgery, University Hospital of Besançon, 25000 Besançon, France.
  • Fath L; Department of ENT-Head and Neck Surgery, University Hospital of Hautepierre, HUS, 67200 Strasbourg, France.
  • Schultz P; Department of ENT-Head and Neck Surgery, University Hospital of Hautepierre, HUS, 67200 Strasbourg, France.
  • Dufour X; Department of ENT-Head and Neck Surgery, University Hospital of Poitiers, 86021 Poitiers, France.
  • Saroul N; Department of ENT-Head and Neck Surgery, University Hospital of Clermont-Ferrand, 63000, France.
  • Evrard D; Department of ENT-Head and Neck Surgery, Bichat University Hospital, APHP, 75018 Paris, France.
  • Lesnik M; Department of ENT-Head and Neck Surgery, Curie Cancer Institute, APHP, 75005 Paris, France.
  • Even C; Department of Oncology, Gustave Roussy Cancer Campus, 94800 Villejuif, France.
  • Costes V; Department of Pathologic Anatomy and onco-biology, University Hospital of Montpellier, France.
  • Thariat J; Department of Radiation Oncology, Cancer center Baclesse, 14076 Caen, France.
  • Taillandier de Gabory LL; Department of ENT-Head and neck surgery, University Hospital of Bordeaux, France.
  • Makeieff M; Department of ENT-Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France.
  • Dubernard X; Department of ENT-Head and Neck Surgery, Robert Debré University Hospital, 51100 Reims, France.
  • Baujat B; Department of ENT-Head and Neck Surgery, Tenon University Hospital, APHP, Sorbonne Universite, 75020 Paris, France. Electronic address: bertrand.baujat@aphp.fr.
Eur J Cancer ; 201: 113922, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38364629
ABSTRACT

OBJECTIVES:

To analyse prognostic factors and survival outcomes of malignant tumors of the external auditory canal, to investigate the role of regional surgery, and adjuvant radiotherapy in early stages and to investigate the role of surgery in operable T4 stage.

SETTING:

A retrospective analysis was conducted on all patients prospectively included in the national database of the French Expertize Network for Rare ENT Cancers (REFCOR) from January 2000 to December 2016.

PARTICIPANTS:

103 patients from 19 reference centers were included. A propensity score matching analysis was applied to enable comparisons between treatments. MAIN OUTCOMES AND

MEASURES:

Event-free survival, overall survival and factors of poor prognosis of the cohort were described. The interest of local and regional surgery and postoperative radiotherapy were evaluated.

RESULTS:

The factors of poor prognosis on event-free survival were immunosuppression (p = 0.002), Karnofsky status less than 90% (p = 0.02), body mass index less than 19 Kg / m2 (p = 0.0009), peripheric facial palsy (p = 0.0016), and positive margin (p = 0.0006). In early stages, locoregional surgery was associated with an increase in event-free survival (p = 0.003, HR = 0.21) versus local surgery alone, while postoperative radiotherapy was not associated with an increase in event-free survival (p = 0.86, HR = 0.91) or overall (p = 0.86, HR = 0.91). In locally advanced stages, locoregional surgery followed by radiotherapy was associated with an increase in event-free survival (p = 0.03, HR = 0.39) and overall (p = 0.02, HR = 0.34) versus chemoradiotherapy alone. CONCLUSION AND RELEVANCE Regional surgery is recommended for early stages of cancers of the external auditory canal. In operable cases, locoregional surgery followed by radiotherapy is recommended.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Conducto Auditivo Externo Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Escamosas / Conducto Auditivo Externo Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2024 Tipo del documento: Article País de afiliación: Francia